All News
Filter News
Found 808,962 articles
-
Nabriva Therapeutics Receives FDA Acknowledgement of New Drug Application Resubmission for Intravenous CONTEPO™ (fosfomycin) for InjectionPDUFA action date set for June 19, 2020
1/8/2020
In the acknowledgement letter for the resubmitted NDA, the FDA stated that Nabriva’s filing was a complete, class 2 response to the complete response letter the FDA issued on April 30, 2019.
-
Aeterna Zentaris Receives NASDAQ Notification Regarding Minimum Bid Price Requirement
1/8/2020
Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecutive business days.
-
New iMednet Release Increases Study Build Efficiency, Improves the User Experience and Enhances Scalability of the Platform
1/8/2020
Mednet, a healthcare technology company, announced a new software release of its all-in-one e-clinical solution, iMednet.
-
Alkermes' Corporate Presentation to be Webcast at the 38th Annual J.P. Morgan Healthcare Conference
1/8/2020
The presentation may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.
-
Valisure And Govzilla Announce A Collaboration Focused On Creating A Platform For Evidence-Based Quality Scores For Drug Products
1/8/2020
Valisure, the first online analytical pharmacy, and Govzilla, an industry leader in leveraging the power of Big Data and AI to make government data accessible and actionable, announced today a collaboration that will create a first-of-its-kind platform with tremendous utility for the healthcare industry.
-
Progentec Raises $5M in Series A Funding Led by Plains Venture Partners
1/8/2020
Progentec, a leader in the development of nextgen diagnostics and digital therapeutics for the management of autoimmune diseases, announced today that it has completed a $5 million Series A funding round led by Plains Venture Partners, the Oklahoma Seed Capital Fund and the Oklahoma Angel Capital Fund II, managed by i2E Management Company (Oklahoma City),
-
Therapeutic Solutions International Reports Inhibition of Microglial Activation with NeuroStilbene
1/8/2020
Therapeutics Solutions International, Inc., (OTC Markets: TSOI) reported today positive animal and human brain cell data demonstrating inhibition in microglial activation of IL-1 beta, IL-6, and TNF-a. NeuroStilbene was also shown to induce neurogenic growth factors and protected from peroxide and kainic-acid induced apoptosis.
-
Kindred Biosciences Announces Half-Life Extension Technology for Canine Antibodies
1/8/2020
Positive results from canine pharmacokinetic study demonstrate up to three-fold increase in antibody half-life
-
BC Platforms Partners with Dante Labs to build Europe’s largest Next Generation Sequencing laboratory for private and public customers
1/8/2020
BC Platforms, a world leader in genomic data management and analytics, today announced that it has formed a partnership with Dante Labs, a global genetic testing and data analysis company specialized in whole genome sequencing and interpretation intended both for Direct To Consumers and larger scale Life Science industry projects
-
Akero Therapeutics To Present At The 2020 J.P. Morgan Healthcare Conference
1/8/2020
J.P. Morgan Healthcare Conference at 7:30 AM Pacific time on Wednesday, January 15, 2020.
-
SyntheticMRs Software SyMRI now in Clinical Routine for Pediatric Whole-brain Myelin Volume Quantification
1/8/2020
SyntheticMR announced today at the American Society of Pediatric Neuroradiology (ASPNR) the clinical use of their novel MR quantification solution, SyMRI, at Cincinnati Children's Hospital Medical Center, for pediatric cases requiring cerebrospinal fluid measurements - and, for the first time, whole-brain myelin.
-
Sienna Announces Fourth Quarter 2019 Results Release Date and Conference Call
1/8/2020
Sienna Senior Living Inc. ("Sienna" or the "Company") (TSX: SIA) announced that it will report its 2019 fourth quarter results after market close on Wednesday, February 19, 2020. Lois Cormack, President and Chief Executive Officer, and Nitin Jain, Chief Financial Officer and Chief Investment Officer, will host a conference call for the investment community the following day, Thursday, February 20, 2020 at 9:30 a.m. (ET).
-
Scientists: Facts Fail to Support Some Conclusions in JAMA Article on Talc Use, Ovarian Cancer
1/8/2020
A recently released article in the Journal of the American Medical Association examining the link between genital talcum powder use and ovarian cancer relied on large-scale studies that were not designed to adequately answer that question, according to clinical researchers who have examined the data.
-
REVIAN® Inc. Announces Issuance of Landmark Patent Covering the Use of Light to Stimulate the Body to Heal Itself
1/8/2020
REVIAN Inc. (formerly PhotonMD Inc.), a medical technology company dedicated to stimulating the body’s natural processes to rejuvenate hair and skin with light, is pleased to announce that the United States Patent and Trademark Office (USPTO) issued U.S. Patent No. 10,265,258 - the seminal patent on the use of proprietary color combinations of light to regenerate living tissue in the body.
-
Vertex to Present at the J.P. Morgan Healthcare Conference on January 13
1/8/2020
The audio portion of management’s remarks can be accessed live through Vertex’s website, www.vrtx.com, in the “Investors” section under the “News and Events” page.
-
Pancreatic Cancer Hits Milestone With Double-Digit Survival Rates
1/8/2020
American Cancer Society's (ACS) Cancer Facts & Figures report, released today, states that the five-year survival rate for pancreatic cancer has increased from 9 to 10%, according to the National Cancer Institute's (NCI) Surveillance, Epidemiology and End Results (SEER)-9 database.
-
Comprehensive Outcomes Management Technologies Announces Partnership with Prime Health Services
1/8/2020
Comprehensive Outcomes Management Technologies, LLC (COMT) and Prime Health Services, Inc. (Prime Health) enter into a partnership on a specialty outcomes-based network effective today.
-
Stemline Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference
1/8/2020
A live webcast of the presentation can be viewed on the company’s website at www.stemline.com.
-
AmerisourceBergen Announces Date and Time for First Quarter Fiscal 2020 Earnings Release
1/8/2020
The Company will host a conference call to discuss the results at 8:30 a.m. ET on January 30, 2020.
-
Stericycle Teams Up with Yext to Modernize the Way Patients Search for and Schedule Appointments with Healthcare Providers
1/8/2020
Stericycle Communication Solutions, an industry leader in patient engagement technology and solutions and a Strategic Alliance Partner of Yext, Inc. (NYSE: YEXT), the Search Experience Cloud Company, today announced the integration of its InQuicker™ online scheduling solution directly into the Yext platform